Patents by Inventor Silke Huettler

Silke Huettler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10596235
    Abstract: The pharmaceutical preparation for the treatment of pancreatic insufficiency comprises a liquid administering form of enzymes.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: March 24, 2020
    Assignee: Nordmark Arzneimittel GmbH & Co. KG
    Inventors: Christian Rämsch, Manfred Kurfürst, Rainer Friedel, Olaf Friedrich, Silke Hüttler
  • Publication number: 20160287679
    Abstract: The pharmaceutical preparation for the treatment of pancreatic insufficiency comprises a liquid administering form of enzymes.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 6, 2016
    Applicant: Nordmark Arzneimittel GmbH & Co. KG
    Inventors: CHRISTIAN RÄMSCH, MANFRED KURFÜRST, RAINER FRIEDEL, OLAF FRIEDRICH, SILKE HÜTTLER
  • Patent number: 8765471
    Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production is mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: July 1, 2014
    Assignee: Nordmark Arzneimittel GmbH & Co. KG
    Inventors: Manfred Kurfuerst, Christian Raemsch, Nicole Raemsch-Guenther, Olaf Friedrich, Silke Huettler, Daniel Brandhorst, Thierry Berney, Pascal Bucher, Heide Brandhorst
  • Publication number: 20130230922
    Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production is mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
    Type: Application
    Filed: April 15, 2013
    Publication date: September 5, 2013
    Applicant: Nordmark, Arzneimittel GmbH & Co., KG
    Inventors: Manfred KURFUERST, Christian Raemsch, Nicole Raemsch-Guenther, Olaf Friedrich, Silke Huettler, Daniel Brandhorst, Thierry Berney, Pascal Bucher, Heide Brandhorst
  • Patent number: 8440445
    Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production ia mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: May 14, 2013
    Assignee: Nordmark Arzneimittel GmbH & Co. KG
    Inventors: Manfred Kurfürst, Christian Raemsch, Nicole Raemsch-Guenther, Olaf Friedrich, Silke Huettler, Daniel Brandhorst, Thierry Berney, Pascal Bucher, Heide Brandhorst
  • Publication number: 20110293590
    Abstract: The pharmaceutical preparation for the treatment of pancreatic insufficiency comprises a liquid administering form of enzymes.
    Type: Application
    Filed: January 29, 2009
    Publication date: December 1, 2011
    Inventors: Christian Rämsch, Manfred Kurfürst, Rainer Friedel, Olaf Friedrich, Silke Hüttler
  • Publication number: 20050142632
    Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production ia mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
    Type: Application
    Filed: June 16, 2004
    Publication date: June 30, 2005
    Inventors: Manfred Kurfurst, Christian Raemsch, Nicole Raemsch-Guenther, Olaf Friedrich, Silke Huettler, Daniel Brandhorst, Thierry Berney, Pascal Bucher, Heide Brandhorst